Clinical Trials Directory

Trials / Unknown

UnknownNCT00538044

Simvatstatin Used to Treat Pulmonary Hypertension

the Clinical Research Using Simvastatin as a Medication to Treat Advanced Secondary Pulmonary Hypertension

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
12 Years – 70 Years
Healthy volunteers
Not accepted

Summary

we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to congenital heart disease or chronic pulmonary embolism before and after the operation.

Detailed description

advanced pulmonary hypertension is refractory to the medication in use nowaday, especially pulmonary hypertension secondary to congenital heart disease or chronic pulmonary embolism.It is revealed that statins may intefere the pathogenisis of the pulmonary hypertension in many key poing, such as improving apotosis or inhiting the proliferation of pulmonary vascular smooth muscle cell. so we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to congenital heart disease or chronic pulmonary embolism before and after the operation.

Conditions

Interventions

TypeNameDescription
DRUGsimvastatinmedication with simvastation on the dosage of 40mg per day before the operation and all the time after the operation

Timeline

Start date
2009-01-01
Completion
2012-01-01
First posted
2007-10-02
Last updated
2007-10-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00538044. Inclusion in this directory is not an endorsement.

Simvatstatin Used to Treat Pulmonary Hypertension (NCT00538044) · Clinical Trials Directory